Pfizer, Tempus collaborate on cancer drug development
The multinational pharma company will access Tempus’ AI-enabled data library to further therapeutic development and advance its portfolio in oncology.
The multinational pharma company will access Tempus’ AI-enabled data library to further therapeutic development and advance its portfolio in oncology.
Go to Source
2023-03-02 21:19
Except for the headline, this story has not been edited by Healthcare Central is published from a syndicated feed.
